TRENDING :  Market Movers  |  Top 50   SPY (0%)    CGC (0%)    CASY (0%)    BABA (0%)    BA (0%)    ATVI (0%)    ARCW (0%)    APC (0%)    SPG (0%)    SCIF (0%)    RYAAY (0%)    PANW (0%)    PAGS (0%)    MU (0%)    MMYT (0%)    MJ (0%)    MHK (0%)    MBRX (0%)    M (0%)    INTC (0%)    GOOGL (0%)    GDXJ (0%)    FRT (0%)    FIS (0%)    EWZ (0%)

Robert Gadimian

Joined: 8/5/2017
Education: Graduate
Trading Experience: 10-20 yrs
I have 20 years of experience in trading. I also have a extensive experience with drug development. I combine technical analysis, valuation of the company and the upcoming short term catalysts before trading. I will set a target price and very tight stop loss limits. I am an active trader and usually sell and jump in again in the same stock until it hits the target price. I like to take my profit after the little runs that the stocks have. It is a more conservative and profitable approach.

Learn More...


Total Recommendations


Open Recommendations

26.12 %

Success Rate


Total Services

My Services

Service NameAvg % Return
since Inception
% SuccessYTD ReturnRiskFees
Biotechnology-1.01 %-2/13426.12 %0.00 %

Closed Recommendations

SymbolServiceTypeStrategy Created Closed% Return
AIMTBiotechnologyEquityBuy Long03/23/1804/03/18-5.04 %
IDRABiotechnologyEquityBuy Long01/26/1804/02/18-9.57 %
ADMSBiotechnologyEquityBuy Long03/23/1804/02/18-6.31 %
AVDLBiotechnologyEquityBuy Long03/23/1803/27/18-4.26 %
PRTKBiotechnologyEquityBuy Long03/23/1803/27/18-3.70 %
CDTXBiotechnologyEquityBuy Long03/23/1803/26/18-9.09 %
CPRXBiotechnologyEquityBuy Long03/23/1803/23/18-2.26 %
AKAOBiotechnologyEquityBuy Long01/02/1803/23/1819.40 %
ADXSBiotechnologyEquityBuy Long03/05/1803/12/1810.61 %
SGYPBiotechnologyEquityBuy Long12/13/1703/05/1811.11 %
LXRXBiotechnologyEquityBuy Long12/21/1702/09/18-13.29 %
NLNKBiotechnologyEquityBuy Long01/12/1802/06/18-6.54 %
PRTKBiotechnologyEquityBuy Long01/26/1802/02/18-4.15 %
TTPHBiotechnologyEquityBuy Long01/11/1802/01/18-15.38 %
QTNTBiotechnologyEquityBuy Long01/26/1801/31/18-8.26 %
ADMPBiotechnologyEquityBuy Long12/21/1701/29/18-14.61 %
ACRXBiotechnologyEquityBuy Long12/13/1701/26/180.00 %
RNNBiotechnologyEquityBuy Long10/25/1701/26/1822.53 %
SCYXBiotechnologyEquityBuy Long01/12/1801/16/18-2.63 %
KDMNBiotechnologyEquityBuy Long12/13/1701/12/188.38 %
TLGTBiotechnologyEquityBuy Long01/11/1801/12/18-4.95 %
TGTXBiotechnologyEquityBuy Long12/07/1701/11/1825.45 %
ARDMBiotechnologyEquityBuy Long01/04/1801/09/18-21.88 %
OVASBiotechnologyEquityBuy Long12/22/1701/04/18-7.59 %
EYEGBiotechnologyEquityBuy Long12/13/1701/03/18-9.92 %
ICPTBiotechnologyEquityBuy Long12/22/1701/02/18-7.58 %
AKTXBiotechnologyEquityBuy Long10/25/1712/22/174.05 %
RXIIBiotechnologyEquityBuy Long11/30/1712/21/17-15.91 %
KALABiotechnologyEquityBuy Long11/10/1712/13/17-7.81 %
EVOKBiotechnologyEquityBuy Long11/14/1712/13/17-10.39 %
ACRXBiotechnologyEquityBuy Long12/07/1712/12/17-9.09 %
LXRXBiotechnologyEquityBuy Long11/30/1712/12/17-4.11 %
OVASBiotechnologyEquityBuy Long11/30/1712/12/17-9.40 %
SGYPBiotechnologyEquityBuy Long11/15/1712/07/17-3.19 %
KDMNBiotechnologyEquityBuy Long11/03/1712/07/17-4.23 %
CNATBiotechnologyEquityBuy Long11/30/1712/06/17-6.92 %
ARLZBiotechnologyEquityBuy Long11/21/1711/30/17-3.27 %
ICPTBiotechnologyEquityBuy Long11/21/1711/28/17-3.77 %
TSROBiotechnologyEquityBuy Long11/15/1711/28/17-7.85 %
ZIOPBiotechnologyEquityBuy Long11/14/1711/21/170.71 %
PTCTBiotechnologyOptionsBuy Puts10/12/1711/17/17-96.43 %
PTCTBiotechnologyOptionsBuy Puts10/02/1711/17/17-96.15 %
ADMPBiotechnologyEquityBuy Long10/18/1711/15/17-10.00 %
ARDXBiotechnologyEquityBuy Long11/03/1711/14/17-8.62 %
TSROBiotechnologyEquityBuy Long11/14/1711/14/17-1.54 %
IOVABiotechnologyEquityBuy Long10/25/1711/14/179.79 %
RDHLBiotechnologyEquityBuy Long11/10/1711/14/17-4.49 %
TCONBiotechnologyEquityBuy Long11/03/1711/13/17-6.78 %
AKAOBiotechnologyEquityBuy Long11/08/1711/13/17-3.97 %
KERXBiotechnologyEquityBuy Long11/08/1711/10/17-4.59 %
ZIOPBiotechnologyEquityBuy Long11/08/1711/10/17-5.06 %
ATNMBiotechnologyEquityBuy Long10/11/1711/08/17-16.38 %
ICPTBiotechnologyEquityBuy Long09/29/1711/08/178.26 %
NVTABiotechnologyEquityBuy Long11/03/1711/07/17-3.73 %
TGTXBiotechnologyEquityBuy Long10/19/1711/03/173.90 %
MNOVBiotechnologyEquityBuy Long10/10/1710/27/177.61 %
KERXBiotechnologyEquityBuy Long10/26/1710/27/17-3.00 %
ARDXBiotechnologyEquityBuy Long10/18/1710/26/17-11.50 %
TSROBiotechnologyEquityBuy Long10/25/1710/26/17-0.35 %
AKAOBiotechnologyEquityBuy Long10/11/1710/25/17-4.90 %
TSROBiotechnologyEquityBuy Long10/19/1710/25/17-3.66 %
RNNBiotechnologyEquityBuy Long10/13/1710/25/17-13.88 %
LXRXBiotechnologyEquityBuy Long10/17/1710/24/17-4.34 %
ACRSBiotechnologyEquityBuy Long10/17/1710/23/17-1.75 %
TGTXBiotechnologyEquityBuy Long10/18/1710/18/17-3.66 %
SGYPBiotechnologyEquityBuy Long10/17/1710/18/17-5.19 %
TSROBiotechnologyEquityBuy Long10/12/1710/18/17-1.21 %
TCONBiotechnologyEquityBuy Long10/03/1710/17/17-13.04 %
QTNTBiotechnologyEquityBuy Long10/02/1710/17/17-6.86 %
ALDXBiotechnologyEquityBuy Long10/04/1710/16/17-7.38 %
ANTHBiotechnologyEquityBuy Long10/12/1710/16/17-6.98 %
IMDZBiotechnologyEquityBuy Long10/12/1710/16/17-2.73 %
AXSMBiotechnologyEquityBuy Long10/02/1710/13/17-7.08 %
ARDXBiotechnologyEquityBuy Long09/19/1710/12/1738.39 %
GBTBiotechnologyEquityBuy Long10/04/1710/12/175.65 %
ACRXBiotechnologyEquityBuy Long08/05/1710/12/17-13.79 %
AERIBiotechnologyEquityBuy Long10/02/1710/11/1720.97 %
TRVNBiotechnologyEquityBuy Long10/02/1710/10/17-6.84 %
AXONBiotechnologyEquityBuy Long10/03/1710/10/17-11.10 %
MTFBBiotechnologyEquityBuy Long09/19/1710/04/1733.49 %
HRTXBiotechnologyEquityBuy Long09/13/1710/03/1714.24 %
FLXNBiotechnologyEquityBuy Long09/29/1710/03/179.74 %
NUVABiotechnologyEquityBuy Long09/25/1710/02/170.11 %
ANTHBiotechnologyEquityBuy Long09/29/1709/29/17-4.11 %
ZGNXBiotechnologyEquityBuy Long09/05/1709/29/17134.40 %
RDHLBiotechnologyEquityBuy Long09/11/1709/28/1721.36 %
CATBBiotechnologyEquityBuy Long09/08/1709/28/1737.93 %
ICPTBiotechnologyEquityBuy Long09/26/1709/27/17-2.03 %
ICPTBiotechnologyEquityBuy Long09/22/1709/26/17-8.90 %
FLXNBiotechnologyEquityBuy Long09/08/1709/25/177.63 %
TRVNBiotechnologyEquityBuy Long09/20/1709/22/17-2.81 %
NBRVBiotechnologyEquityBuy Long09/20/1709/22/17-2.28 %
VSARBiotechnologyEquityBuy Long09/14/1709/20/1721.88 %
IDRABiotechnologyEquityBuy Long09/05/1709/19/1722.58 %
ACRSBiotechnologyEquityBuy Long09/11/1709/18/17-4.92 %
RXDXBiotechnologyEquityBuy Long09/13/1709/18/1715.38 %
NBRVBiotechnologyEquityBuy Long09/13/1709/15/17-7.06 %
VSARBiotechnologyEquityBuy Long09/13/1709/14/17-4.76 %
TGTXBiotechnologyEquityBuy Long09/07/1709/12/17-4.88 %
VSARBiotechnologyEquityBuy Long09/08/1709/12/17-5.18 %
HZNPBiotechnologyEquityBuy Long08/14/1709/11/1713.91 %
ADMPBiotechnologyEquityBuy Long09/08/1709/11/17-2.75 %
RDHLBiotechnologyEquityBuy Long09/08/1709/11/17-3.42 %
PETXBiotechnologyEquityBuy Long08/30/1709/08/1711.54 %
AUPHBiotechnologyEquityBuy Long09/06/1709/08/178.99 %
PCRXBiotechnologyEquityBuy Long08/30/1709/07/170.41 %
AXSMBiotechnologyEquityBuy Long08/30/1709/07/17-9.00 %
AXSMBiotechnologyEquityBuy Long08/30/1709/07/17-9.00 %
AXSMBiotechnologyEquityBuy Long08/30/1709/07/17-9.00 %
NVTABiotechnologyEquityBuy Long08/28/1709/06/17-2.44 %
AUPHBiotechnologyEquityBuy Long09/01/1709/05/17-2.48 %
LXRXBiotechnologyEquityBuy Long08/31/1709/05/17-2.32 %
FGENBiotechnologyEquityBuy Long08/23/1708/31/1713.99 %
INSMBiotechnologyEquityBuy Long08/17/1708/30/172.73 %
INSMBiotechnologyEquityBuy Long08/24/1708/30/17-2.28 %
PGNXBiotechnologyEquityBuy Long08/10/1708/30/1722.80 %
KMDABiotechnologyEquityBuy Long08/16/1708/30/172.41 %
NVTABiotechnologyEquityBuy Long08/22/1708/24/176.05 %
PCRXBiotechnologyEquityBuy Long08/22/1708/23/17-3.45 %
PCRXBiotechnologyEquityBuy Long08/14/1708/21/17-3.66 %
OMERBiotechnologyEquityBuy Long08/16/1708/21/17-5.60 %
ADMPBiotechnologyEquityBuy Long08/05/1708/17/170.00 %
KMDABiotechnologyEquityBuy Long08/14/1708/15/17-5.49 %
AXSMBiotechnologyEquityBuy Long08/05/1708/14/17-14.05 %
PCRXBiotechnologyEquityBuy Long08/10/1708/11/17-2.59 %
VSTMBiotechnologyEquityBuy Long08/09/1708/10/17-7.04 %
ARLZBiotechnologyEquityBuy Long08/05/1708/10/17-5.17 %
LXRXBiotechnologyEquityBuy Long08/09/1708/10/17-2.88 %
SRPTBiotechnologyEquityBuy Long08/05/1708/10/17-3.34 %
ABIOBiotechnologyEquityBuy Long08/09/1708/10/17-11.11 %
PGNXBiotechnologyEquityBuy Long08/05/1708/09/17-7.09 %
ADMPBiotechnologyEquityBuy Long08/07/1708/09/17-5.32 %
ABIOBiotechnologyEquityBuy Long08/05/1708/09/17-12.82 %
LXRXBiotechnologyEquityBuy Long08/05/1708/07/17-2.72 %


3 "Weird" Indicators That Could Be Pointing To A Recession

In the most recent issue of my premium trading service Income Trader I didn t make a trade recommendation Not a single one I ll admit it s a little strange I ve rarely done this since beginning the newsletter more than six years ago It s not what my premium subscribers

3 Dividend Stocks That Should Pay You the Rest of Your Life

A handful of stocks have paid a dividend for 100 years or more and those are well into Dividend Aristocrat status a title any dividend company would love to have But the next 50 or 100 years may be dominated by a new generation of aristocrats and previous ones may not be

Why Tencent Shouldn't Launch a Gaming Smartphone

Tencent NASDAQOTH TCEHY is mulling the development of 160 a gaming smartphone according to Chinese media site 36KR The tech giant is reportedly holding talks with Asus Razer Xiaomi s NASDAQOTH XIACF Black Shark and Wentai to produce the device The first

Here's How 59% of Americans Are Putting Their Loved Ones' Financial Future at Risk

If you have a spouse or children you probably want nothing more than to provide for them and protect them But if you don t have life insurance you re effectively doing nothing to ensure that they re taken care of in the event of your untimely passing Only 41 of Americans have

Chevron Is Getting a Hidden Gem in the Anadarko Deal

The main reason Chevron NYSE CVX is paying 50 billion to acquire Anadarko NYSE APC is to bulk up its industry leading position in the fast growing Permian Basin An added benefit is that the deal will also bolster the oil giant s presence in the Gulf of Mexico add

Chipotle Earnings: Will the Momentum Continue?

If there were ever a story of an epic turnaround Chipotle NYSE CMG would be in the running After enduring a seemingly endless series of foodborne illness outbreaks the company has recovered its footing under the tutelage of CEO Brian Niccol Since bottoming out early last year

3 Growth Stocks for In-the-Know Investors

Investors love growth stocks That s because companies that can consistently grow their sales and earnings at high rates tend to deliver market crushing returns Some growth stocks however manage to fly under the radar of investors because they operate in out of favor industries

Check Point Delivers Mixed Earnings

Network security company Check Point Software Technologies NASDAQ CHKP started off 2019 by delivering a mixed set of first quarter earnings The initial market reaction to the earnings wasn t positive 160 but as ever the devil is in the details Let s take a closer look at

4 Retirement Mistakes You Can't Afford to Make

Retirement is supposed to be an enjoyable period of life but if you don t plan for it properly the opposite might end up holding true Here are four mistakes that could derail your retirement and leave you cash strapped and miserable at the same time 1 Relying on Social

Microsoft Earnings: Will Cloud Computing Continue to Provide Momentum?

Over the past year Microsoft NASDAQ MSFT has continued its relentless trek upward Shares of the software and cloud computing giant have gained nearly 28 over the past year eclipsing the 7 rise of the S amp P 500 Its stock price has been driven by solid growth in its

Credit Inquiries and Your FICO® Score: What You Need to Know

How do credit inquiries fit into your FICO Score Image source Getty Images The FICO scoring formula contains five categories of information and credit inquiries are included in one of the least important categories Specifically the new credit category of the FICO credit

3 Surprising Stocks Hitting New Lows Last Week

Stocks are rolling in 2019 with the three major market indexes up between 14 and 21 so far this young year Some investments are faring even better But some stocks just can t seem to catch a break Sohu com NASDAQ SOHU Trivago NASDAQ TRVG and Tanger

Why a Bright Outlook in Life Can Help You Save More Money

It s no surprise that Americans are struggling when it comes to saving for retirement In fact 42 of baby boomers don t have anything at all saved for retirement according to a report from the Insured Retirement Institute and only 28 think they re doing a good job of preparing

5 Things You Probably Didn't Know About Social Security

Social Security is a cornerstone of most retirement plans but people have a lot of misconceptions about it If you don t have a realistic understanding of how it works or how your choices affect your benefits you could wind up in hot water Here are five important things that

A Reduced Payout Could Be Imminent for These High-Yield Dividend Stocks

Dividend yields tend to rise as investors get nervous about the payout s long term sustainability When they reach double digits it s usually a warning sign that a reduction could be ahead That certainly seems to be the case for ultra high yielding energy companies BP Prudhoe
© StockHoot LLC 2019. Made in Chicago.

Terms  | Privacy Policy  | Contact Us  | Feedback 

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.

Cryptocurrency data provided by CryptoCompare